Business Information
The group's principal activities are to develop, manufacture and market medical products. These products are designed to assist or replace the pumping function of the failing heart. The group manufactures and sells the bvs 5000 bioventricular support system, a temporary heart assist device. Bvs is an advanced heart assist device for the temporary treatment of all patients with failing but potentially recoverable hearts. It also serves a different function than bridge-to-transplant devices, which are intended for long-term use by patients awaiting a heart transplant. The group also conducts research and development relating to other devices to replace or support the pumping function of the heart. The group's trademarks include abiomed, bvs, abiocor, angioflex, abiofit and ab5000. The group operates in the United States.
|
|
Name |
Title
|
Email
|
| Michael Minogue | Chmn., CEO, Pres. | N/A | | David Weber | COO | N/A | | Thorsten Siess | CTO | N/A | | John Pristas | Dir. - Clinical Operations | N/A | | Joyce Bruzzeze | Hospital Marketing | N/A |
|
|
Year |
Sales |
Net Income |
| 2007 | 50,649 | (27,881) | | 2006 | 43,670 | (29,449) | | 2005 | 38,216 | (2,342)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
